You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-vascular endothelial growth factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Adult Diabetic Macular Edema and Suboptimal Response to

Not yet recruiting
  • Diabetic Macular Edema
    • (no location specified)
    Jul 31, 2023

    Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

    Recruiting
    • Macular Edema Due to Type 2 Diabetes Mellitus
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Feb 26, 2023

    Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

    Recruiting
    • Diabetic Macular Edema
    • Cataract
    • Walnut Creek, California
      Bay Area Retina Associates
    Mar 1, 2022

    Following Intensive Anti-VEGF Therapy in Wet AMD

    Completed
    • Age-Related Macular Degeneration
    • Budapest, Hungary
    • +1 more
    Dec 28, 2022

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Ocular Adverse Events in Neovascular Age-related Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration (nAMD)
    • AR-14034 SR implant lower dose
    • +3 more
    • (no location specified)
    Mar 3, 2023

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

    Recruiting
    • Retinal Vein Occlusion
    • Aflibercept Ophthalmic
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Jan 5, 2022

    Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb

    Recruiting
    • Age Related Macular Degeneration
    • recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
    • Xuzhou, Jiangsu, China
      XuZhou Central Hospital
    Feb 7, 2022

    Intravitreal Injection Site and Perceived Pain

    Recruiting
    • Pain
    • Intravitreal injection site
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 19, 2023

    Retinal Pigment Epithelium Detachment in Neovascular Age-related

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • Anti-vascular endothelial growth factor therapy
    • Krasnodar, Russian Federation
      The S.N. Fyodorov Eye Microsurgery State Institution
    Jan 12, 2022

    Metastatic Colorectal Cancer, Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Recurrent Trial in Hefei

    Completed
    • Metastatic Colorectal Cancer
    • +2 more
    • Hefei, Anhui, China
      The Second Hospital of Anhui Medical University
    Oct 27, 2021

    Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

    Active, not recruiting
    • Recurrent Brain Neoplasm
    • Bevacizumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Eyes That Do Not Meet Eligibility Criteria of Clinical Trials on

    Completed
    • Age-related Macular Degeneration
    • Intravitreal anti-vascular endothelial growth factor injection
    • Seoul, Korea, Republic of
      Jae Hui Kim
    Apr 6, 2021

    Macular Disease Trial in Omaha

    Suspended
    • Macular Disease
      • Omaha, Nebraska
      • +1 more
      Sep 16, 2022

      Diabetic Macular Edema, Cataract Trial in Atlanta (Aflibercept injected Pre- and Post-operatively, Aflibercept injected

      Withdrawn
      • Diabetic Macular Edema
      • Cataract
      • Aflibercept injected Pre- and Post-operatively
      • Aflibercept injected intraoperatively
      • Atlanta, Georgia
      • +1 more
      Dec 23, 2020

      Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

      Recruiting
      • Recurrent Fallopian Tube Carcinoma
      • +2 more
      • Bevacizumab
      • +4 more
      • Phoenix, Arizona
      • +2 more
      Jun 27, 2022

      Exudative Age-related Macular Degeneration Trial (intravitreal injection)

      Completed
      • Exudative Age-related Macular Degeneration
      • intravitreal injection
      • (no location specified)
      Apr 19, 2022

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Completed
      Has Results
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +8 more
      • Bevacizumab
      • Irinotecan Sucrosofate
      • Chicago, Illinois
        Northwestern University
      Dec 21, 2022

      Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial

      Completed
      Has Results
      • Neovascular Age-related Macular Degeneration
      • Wet Macular Degeneration
      • Palo Alto, California
      • +4 more
      Jun 5, 2020

      Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

      Not yet recruiting
      • Ovarian Clear Cell Adenocarcinoma
      • +14 more
      • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
      • +4 more
      • Buffalo, New York
      • +1 more
      Dec 16, 2022

      Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

      Recruiting
      • Resectable Hepatocellular Carcinoma
      • +4 more
      • Atezolizumab
      • +2 more
      • Houston, Texas
      • +1 more
      Oct 12, 2022

      Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

      Not yet recruiting
      • Fallopian Tube Carcinosarcoma
      • +10 more
      • Bevacizumab
      • +4 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Dec 29, 2022